It is surprising that Anne Wojcicki, founder and former CEO of 23AndMe, will regain control of DNA’s assets, according to a 23AndMe press release. In May, a company called Regeneron acquired 23andMe for a bankruptcy auction of $256 million, but Wojcicki’s nonprofit TTAM Research Institute can reopen with a “unauthorized” offer of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a price of $305 million, a Wall Street Journal Report.
A bankruptcy judge agreed to reopen the bid for 23AndMe for at least $10 million at Regeneron Top Wojcicki. WSJ. Regeneron refused, leaving 23AndMe in control of TTAM assuming the judge approved the agreement. A hearing to consider a new deal is scheduled for June 17, 2025.
Regeneron had previously planned to retain all of the company’s employees and continue to provide consumer DNA testing suites. In addition to answering client questions about ancestors, 23AndMe’s genetic data is a valuable way to identify possible health risks and in Regeneron serves as a tool for identifying drug targets.
It is not clear what Wojcicki is going to do next, but the announcement from 23andMe includes customer data and privacy protection lists TTAM Institute has agreed, including continuing to allow customers to select data and opt out of the study, and identifying consumers’ privacy committees and identifying “private people who do not agree or disagree” without having to sell or transfer genetic data unless they are sold or transferred in another Bulbistery.
Wojcicki’s plan has been Wojcicki’s plan since it declared bankruptcy on March 23, 2025. She initially resigned from the company’s CEO.
“I am very pleased that the TTAM Institute will continue to perform the 23andme task to help people gain, understand and benefit from the human genome,” Wojcicki said. “We believe it is crucial that individuals have the ability to have choice and transparency in their genetic data and have the opportunity to continue to understand their ancestors and health risks.”
23AndMe suffered a data breach in 2023, which affected millions of customers and Volkswagen layoffs in 2024, which affected 40% of the company’s employees.
If you purchase something through the links in this article, we may earn commissions.
